Table 3.
label for genetic study | Family | gender | Age (year) | Age at onset (year) | Initial presentation | Ophthalmic signs | Modality | Cysts on ultrasound | histopat hology | NPHP 1 homozygous deletion |
---|---|---|---|---|---|---|---|---|---|---|
A | A5225 | female | 12 | 4 | AOC/ P&P | RP | HD | + | ND | No |
B | A5226 | female | 15 | 12 | AOC | RP/RD | HD | − | ND | No |
C | A5227 | Male | 20 | 10 | P&P/D P/GD | RD | KTx | + | ND | No |
D1 | A5228-111 | female | 15 | 8 | P&P | RP | mRRT | + | ND | No |
D2 | A5228-112 | female | 22 | 7 | AOC | RP | KTx | + | ND | No |
E | A5229 | female | 14 | 11 | P&P/ GR | RD | HD | − | ND | No |
F | A5230 | male | 16 | 12 | AOC | RP/RD | HD | + | ND | No |
G | A5231 | female | 20 | 10 | AOC | RD | KTx | − | ND | No |
006 | A5232 | female | 16 | 11 | P&P/G D | RP | KTx | + | Yes | No |
007 | A5233 | female | 17 | 12 | P&P/D P/GD | RFD | mRRT | + | Yes | No |
008 | A5234 | male | 12 | 7 | P&P | RFD | mRRT | + | Yes | Yes |
009 | A5235 | male | 15 | 14 | AOC | RFD | mRRT | + | yes | No |
011 | A5236 | male | 14 | 10 | P&P/ DP | RP/RD | mRRT | + | yes | No |
012 | A5237 | female | 17 | 14 | AOC | RFD | KTx | + | ND | Yes |
013 | A5238 | male | 12 | 11 | AOC | RP | HD | − | ND | No |
014 | A5239 | female | 15 | 6 | P&P/G D | RFD | PD | + | Yes | No |
A to G are families from Qeshm and 006 to 014 are families from Isfahan province. mRRT: medical renal replacement therapy, RTx: renal transplantation, HD: hemodialysis, PD: peritoneal dialysis, ND: not done. Histopathological triad: tubular basement membrane thickening and disruption, interstitial infiltration and fibrosis, and tubular atrophy and dilatation with or without cyst formation. P&P: polyuria and polydipsia, DP: delayed puberty, GR: growth retardation, RP: retinitis pigmentosa, RD: retinal dystrophy, RFD: Refractory disturbances, AOC: acute on chronic renal failure.